Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance (Q44229688)

1 December 2017

Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance (English)

1 reference

1 December 2017

1

1 reference

1 December 2017

Cristina Colombo

4

0 references

Enrico Smeraldi

series ordinal

5

object named as

Enrico Smeraldi

1 reference

1 December 2017

Adelio Lucca

2

1 reference

PubMed ID

12452541

1 December 2017

Francesca Brambilla

series ordinal

3

1 reference

1 December 2017

1 October 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 December 2017

1 reference

1 December 2017

26

1 reference

1 December 2017

6

1 reference

1 December 2017

1167-1170

1 reference

Ongoing lithium treatment prevents relapse after total sleep deprivation.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Amitriptyline in combination with repeated late sleep deprivation versus amitriptyline alone in major depression. A randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Cytokine production and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

The effects of psychological stress on plasma interleukin-6 activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Immune–inflammatory markers in patients with seasonal affective disorder: effects of light therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Cerebrospinal cytokine levels in patients with acute depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

The in vitro immunosuppressive effects of moclobemide in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

In vitro immunoregulatory effects of lithium in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Cytokine production and serum proteins in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Indicators of immune activation in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Modulation of cytokine expression by hypericum extract

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900255-5

7 January 2021

10.1016/S0278-5846(02)00255-5

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12452541